Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study

BACKGROUND: A specific subset of psoriasis patients is characterized by subclinical inflammatory changes. These patients frequently present with arthralgia and have a higher risk to develop psoriatic arthritis (PsA). We hypothesized that IL-17A inhibition in this subset of patients can intercept the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Kampylafka, Eleni, Simon, David, d’Oliveira, Isabelle, Linz, Christina, Lerchen, Veronika, Englbrecht, Matthias, Rech, Juergen, Kleyer, Arnd, Sticherling, Michael, Schett, Georg, Hueber, Axel J.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6659205/
https://ncbi.nlm.nih.gov/pubmed/31349876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1957-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars